FI903144A0 - Modifierade vp1/p2a zoner i snuvvirussystemet. - Google Patents

Modifierade vp1/p2a zoner i snuvvirussystemet.

Info

Publication number
FI903144A0
FI903144A0 FI903144A FI903144A FI903144A0 FI 903144 A0 FI903144 A0 FI 903144A0 FI 903144 A FI903144 A FI 903144A FI 903144 A FI903144 A FI 903144A FI 903144 A0 FI903144 A0 FI 903144A0
Authority
FI
Finland
Prior art keywords
snuvvirussystemet
zoner
modified
protease
trans
Prior art date
Application number
FI903144A
Other languages
English (en)
Inventor
Wolfgang Sommergruber
Peter Volkmann
Friederike Fessl
Ingrid Maurer-Fogy
Ernst Kuechler
Dieter Blaas
Timothy Skern
Manfred Zorn
Herbert Auer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of FI903144A0 publication Critical patent/FI903144A0/fi
Priority to FI951852A priority Critical patent/FI951852A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1009Picornaviridae, e.g. hepatitis A virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32711Rhinovirus
    • C12N2770/32722New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
FI903144A 1989-06-25 1990-06-21 Modifierade vp1/p2a zoner i snuvvirussystemet. FI903144A0 (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI951852A FI951852A0 (fi) 1989-06-25 1995-04-19 Menetelmä testijärjestelmän valmistamiseksi

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3920860 1989-06-25
DE4018376 1990-06-08

Publications (1)

Publication Number Publication Date
FI903144A0 true FI903144A0 (fi) 1990-06-21

Family

ID=25882343

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903144A FI903144A0 (fi) 1989-06-25 1990-06-21 Modifierade vp1/p2a zoner i snuvvirussystemet.

Country Status (16)

Country Link
EP (2) EP0410147B1 (fi)
JP (1) JPH04503608A (fi)
KR (1) KR920701439A (fi)
AT (1) ATE114717T1 (fi)
AU (2) AU644078B2 (fi)
CA (1) CA2019661A1 (fi)
DE (2) DE59007818D1 (fi)
DK (1) DK0410147T3 (fi)
ES (1) ES2064537T3 (fi)
FI (1) FI903144A0 (fi)
GR (1) GR3015192T3 (fi)
IE (2) IE950434L (fi)
IL (2) IL94841A0 (fi)
NO (1) NO902789L (fi)
NZ (1) NZ234212A (fi)
PT (1) PT94458B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8318423B2 (en) 2004-07-06 2012-11-27 Focus Diagnostics, Inc. Methods and compositions for detecting rhinoviruses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0263903A1 (en) * 1986-10-10 1988-04-20 E.I. Du Pont De Nemours And Company Method for preparing specific inhibitors of virus-specified proteases
DE3885431D1 (de) * 1987-12-23 1993-12-09 Boehringer Ingelheim Int Expression der viral kodierten Protease P2A des HRV2.

Also Published As

Publication number Publication date
WO1991000348A3 (de) 2004-04-29
AU5779690A (en) 1991-01-03
PT94458A (pt) 1991-02-08
EP0410147A1 (de) 1991-01-30
IE902270A1 (en) 1991-01-16
EP0410147B1 (de) 1994-11-30
DE59007818D1 (de) 1995-01-12
KR920701439A (ko) 1992-08-11
IL112507A0 (en) 1995-05-26
PT94458B (pt) 1997-02-28
IL94841A0 (en) 1991-04-15
AU644078B2 (en) 1993-12-02
JPH04503608A (ja) 1992-07-02
CA2019661A1 (en) 1990-12-25
NO902789L (no) 1990-12-27
IE950434L (en) 1990-12-25
AU3524593A (en) 1993-05-27
ATE114717T1 (de) 1994-12-15
GR3015192T3 (en) 1995-05-31
NZ234212A (en) 1993-03-26
WO1991000348A1 (de) 1991-01-10
DK0410147T3 (da) 1995-03-13
NO902789D0 (no) 1990-06-22
IE902270L (en) 1990-12-25
IE66395B1 (en) 1995-12-27
DE4020211A1 (de) 1991-01-17
EP0602687A1 (de) 1994-06-22
AU657205B2 (en) 1995-03-02
ES2064537T3 (es) 1995-02-01

Similar Documents

Publication Publication Date Title
DE60143292D1 (de) Varianten des menschlichen Koagulationsfaktors VII
DE69434689D1 (de) Adenovirale vektoren für die behandlung der hämophilie
ATE320495T1 (de) Kalziumfreie subtilisin mutanten
DE60227361D1 (de) Computer vermitteltes assembly von polynucleotiden kodierend für ein zielgerichtetes polypeptide
DE69833784D1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
DE68914664D1 (de) Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden.
BR9810701A (pt) Proteìna "swollenina" de trichoderma reesei e seqâências de codificação de dna
DE69329195D1 (de) Rekombinante dna moleküle die aminopeptidase enzyme kodieren und ihre anwendung für die herstellung von impfstoffen gegen helminth infektionen
DE69535696D1 (de) Tripeptidyl-aminopeptidase
DE3853156D1 (de) Polyestergewebe zur herstellung von elektrophoresegelen und elektrophoresegel.
TR199802376T1 (xx) Aspergıllus Phoenıces'den Oksalat Dekarboksilaz Kodlayan Gen.
ATE218616T1 (de) Humanes zirkulierendes cytokin cc-1
FI903144A0 (fi) Modifierade vp1/p2a zoner i snuvvirussystemet.
DE69534470T2 (de) Lgmd- gen kodierend für eine calcium-abhängige protease
SE9602822D0 (sv) New receptor
ES2060134T3 (es) Inhibidor de tejido de metaloproteasas (timp-2).
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
ATE242883T1 (de) Verfahren zur bestimmung von blutgerinnungsfaktoren viii und ix
SE9604439D0 (sv) New receptor
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
TH9496EX (th) สายพันธ์กลายของซับสติลิซีน
RU96124779A (ru) Днк, кодирующая кератиназу bacilus licheniformis pwd-1
ATE279520T1 (de) Immunreaktives protein vp26 des varicella-zoster- virus (vzv) und seine diagnostische verwendung
TH6622A (th) พาหะแสดงออกสำหรับการสังเคราะห์โปรตีนและพลาสติคเรพิคอนตลับลำดับสำหรับใช้ในการสร้างพาหะ

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: BOEHRINGER INGELHEIM INTERNATIONAL GMBH